Gland Pharma Limited Overview
Get informed when a big investor buys or sells
+ Follow76.42
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for GLAND.BO is 76.42. That is above the sector sector average of -0.06. Investors often review this figure alongside Gland Pharma Limited's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, GLAND.BO currently prints 76.42 for PEG ratio, while the sector average sits near -0.06. That is roughly 130596.8% above the sector mean. Large gaps often invite a closer look at Gland Pharma Limited's growth, margins, and balance sheet.
A PEG ratio of 76.42 for Gland Pharma Limited is not 'good' or 'bad' on its own. Compare it with the peer average (-0.06) and with GLAND.BO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting GLAND.BO's PEG ratio (76.42), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
